ERS International Congress, Madrid 2019

Browse by day:
Saturday, 28.09.2019
Sunday, 29.09.2019
Monday, 30.09.2019
Tuesday, 01.10.2019
Wednesday, 02.10.2019


View the presentations you missed during Congress!

More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.


Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.

Beyond T2 mechanisms in asthma: who are the other players?

Hot topic
Chairs: K. Chung (London, United Kingdom), M. Al-Ahmad (Kuwait, Kuwait), N. Jarjour (Madison, United States of America)
Aims: to identify the unmet need for a valid definition of non-T2 severe asthma; to discuss current definitions and their limitations (including those in the relevant ATS/ERS and GINA guidelines); to emphasise the role of corticosteroids in supressing T2 activity and the need for stepdown trials to define non-T2 disease; to ascertain the role of sex hormones in the pathogenesis of asthma onset, progression and/or exacerbations; to discuss the potential for targeting sex hormones and identifying new pathways that can be exploited for therapeutic interventions; to discuss the role of airway dysbiosis in severe asthma and the potential for targeting the microbiome with antibiotics, probiotics or phage therapies; to review novel clinical trial designs employing complex interventions to treat non-T2 severe asthma, focusing on comparisons with standard of care and methods to integrate these trials into existing monoclonal therapy pathways; to discuss the role of adaptive clinical trials and multi-arm multi-stage trial designs in the context of severe asthma; to highlight parallels with other disciplines such as oncology and rheumatology.
Defining non-T2 asthma: moving beyond the absence of T2 activity
S. Siddiqui (Leicester, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
The role of sex hormones in severe asthma
A. Bossios (Stockholm, Sweden)
WebcastSlide presentation
WebcastSlide presentation
Targeting microbes and dysbiosis in severe asthma
J. Simpson (New Lambton, Australia)
WebcastSlide presentation
WebcastSlide presentation
Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials?
L. Brown (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation